Search Results

and the intracellular helix 8 move outward from the receptor core to make room for the G-protein (Lu, Zhao namely CCL15L (residues 26-92) and CCL15M (residues 27-92), while the third structure lacks a ligand (Shao conformational change of Y2917.43 tilted toward TM2, a model supported by mutagenesis experiments (Shao

Zhao et al. 2019). Zhao et al. 2019) together with confocal fluorescence microscopy.

Zhao, P., et al., Activation of the GLP-1 receptor by a non-peptidic agonist. 

Elva Zhao About this episode Elva is currently a research fellow at the Monash Institute of Pharmaceutical Elva moved to Canada where she obtained her Ph.D. at the University of Western Ontario, working on the In her spare time, Elva likes to run in the mountains, play with Tilly (a 9-year old retired greyhound Join me to learn more about Elva, class B GPCRs, and Tilly. Dr. Elva Zhao on the web LinkedIn Monash University Pubmed Twitter Dr.

Authors Jie Xiong , Yu-Ting Dai , Wen-Fang Wang , Hao Zhang , Chao-Fu Wang , Tong Yin , Shu Cheng , Hui-Juan Yue Zhu , Hong-Mei Yi , Xu-Feng Jiang , Jia-Yi Chen , Li Wang , Peng-Peng Xu , Sai-Juan Chen , Wei-Li Zhao

Authors Yanni Xi, Zhenya Min, Mianxue Liu, Xueqin Li, Zhao-Hua Yuan Tags P2Y12R , P2Y12R inhibitors ,